New Insights on Hyperbaric Oxygen Therapy for Cancer
- Authors
-
-
Michael J. González
University of Puerto Rico, Medical Sciences Campus, School of Public Health, USA; EDP University, Naturopathic Sciences Program, USA; Universidad Central del Caribe, School of Chiropractic, USA; Centro Médico Regenerativo (CMR), Bayamón and Caguas Puerto Rico, USA and Berdiel Clinic, Ponce Puerto Rico, USA -
Jorge R. Miranda-Massari
University of Puerto Rico, Medical Sciences Campus, School of Pharmacy, USA and EDP University, Naturopathic Sciences Program, USA -
Michael Joseph Gonzalez
Centro Médico Regenerativo (CMR), Bayamón and Caguas Puerto Rico, USA -
Jose Olalde
Centro Médico Regenerativo (CMR), Bayamón and Caguas Puerto Rico, USA -
Miguel J. Berdiel
Berdiel Clinic, Ponce Puerto Rico, USA -
Liza Cardona
EDP University, Naturopathic Sciences Program, USA
-
- Keywords:
- Hyperbaric Oxygen, Cancer, oxygen, degenerative diseases, hypoxia, senesence
- Abstract
-
Hypoxia is a critical characteristic of malignant tumors and involves enhanced cell survival, angiogenesis, glycolytic metabolism, and metastasis. Hyperbaric oxygen treatment (HBOT) has been used to improve and cure disorders involving hypoxia and ischemia, HBOT enhances the amount of dissolved oxygen in the plasma and thereby increasing O2 delivery to the tissue. Studies on HBOT and cancer have mostly focused on whether enhanced oxygen may act as a promoter of cancer. As oxygen is believed to be required for all the major processes of wound healing, including angiogenesis, this particular idea would give the impression that HBOT will promote cancer growth and recurrence. Nevertheless, this is not the case since the use of HBOT in patients with malignancies should be considered safe and therapeutic. There is no evidence indicating that HBO neither acts as a stimulator of tumor growth nor as an enhancer of recurrence. On the other hand, there is evidence that implies that HBO has tumor-inhibitory effects, this manuscript pretends to expand our knowledge on the effect and the mechanisms behind tumor oxygenation by HBOT.
- References
-
Chen SY, Tsuneyama K, Yen MH, Lee JT, Chen JL, Huang SM. Hyperbaric oxygen suppressed tumor progression through the improvement of tumor hypoxia and induction of tumor apoptosis in A549-cell-transferred lung cancer. Sci Rep 2021; 11(1):12033. https://doi.org/10.1038/s41598-021-91454-2
Manish KC, Rodriguez JR, Gonzalez FL, Arroyo NA, Garcia KM, Olalde J, Berdiel MJ, Morales-Borges R, Miranda-Massari JR, Gonzalez MJ. Research advances in hyperbaric oxygen therapy use in cancer: A Review. Am Res J Oncology 2021; 3(1): 1-6.
Poff AM, Ari C, Seyfried TN, D'Agostino DP. The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer. PLoS One 2013; 8(6): e65522. https://doi.org/10.1371/journal.pone.0065522
Moen I, Stuhr LE. Hyperbaric oxygen therapy and cancer a review. Target Oncol 2012; 7(4): 233-42. https://doi.org/10.1007/s11523-012-0233-x
Daruwalla J, Christophi C. Hyperbaric oxygen therapy for malignancy: a review. World J Surg 2006; 30(12): 2112-31. https://doi.org/10.1007/s00268-006-0190-6
Herrera-Campos AB, Zamudio-Martinez E, Delgado-Bellido D, Fernández-Cortés M, Montuenga LM, Oliver FJ, Garcia-Diaz A. Implications of Hyperoxia over the Tumor Microenvironment: An Overview Highlighting the Importance of the Immune System. Cancers (Basel) 2022; 14(11): 2740. https://doi.org/10.3390/cancers14112740
Narkowicz C K, Vial JH and McCartney PW. Hyperbaric Oxygen Therapy Increases Free Radical Levels in the Blood of Humans, Free Radical Research Communications 1993; 19(2): 71-80. https://doi.org/10.3109/10715769309056501
Weber SU, Koch A, Kankeleit J, Schewe JC, Siekmann U, Stüber F, Hoeft A, Schröder S. Hyperbaric oxygen induces apoptosis via a mitochondrial mechanism. Apoptosis 2009; 14(1): 97-107. https://doi.org/10.1007/s10495-008-0280-z
Gonzalez MJ, Seyfried T, Nicolson GL, Barclay BJ, Matta J, Vasquez A, D’ Agostino D, Olalde J, Duconge J, Hunninghake R, Berdiel MJ, Cintrón A. Mitochondrial Correction: A New Therapeutic Paradigm for Cancer and Degenerative Diseases. J Orthomolec Med 2018; 33(4): 1-20.
Hadanny A, Forer R, Volodarsky D, Daniel-Kotovsky M, Catalogna M, Zemel Y, Bechor Y, Efrati S. Hyperbaric oxygen therapy induces transcriptome changes in elderly: a prospective trial. Aging (Albany NY) 2021; 13(22): 24511-24523. https://doi.org/10.18632/aging.203709
Gupta K, Madan E, Sayyid M, Arias-Pulido H, Moreno E, Kuppusamy P, Gogna R. Oxygen regulates molecular mechanisms of cancer progression and metastasis. Cancer Metastasis Rev 2014; 33(1): 183-215. https://doi.org/10.1007/s10555-013-9464-2
Dave KR, Prado R, Busto R, Raval AP, Bradley WG, Torbati D, Pérez-Pinzón MA. Hyperbaric oxygen therapy protects against mitochondrial dysfunction and delays onset of motor neuron disease in Wobbler mice. Neuroscience 2003; 120(1): 113-120. https://doi.org/10.1016/S0306-4522(03)00244-6
Rossignol DA, Bradstreet JJ, Van Dyke K, Schneider C, Freedenfeld SH, O’Hara N, Cave S, Buckley JA, Mumper EA, Frye RE. Hyperbaric oxygen treatment in autism spectrum disorders. Med Gas Res 2012; 2(16). https://doi.org/10.1186/2045-9912-2-16
Palzur E, Zaaroor M, Vlodavsky E, Milman F, Soustiel JF. Neuroprotective effect of hyperbaric oxygen therapy in brain injury is mediated by preservation of mitochondrial membrane properties. Brain Res 2008; 1221: 126-133. https://doi.org/10.1016/j.brainres.2008.04.078
Poff AM, Ward N, Seyfried TN, Arnold P, D’Agostino DP. Non-toxic metabolic management of metastatic cancer in VM mice: novel combination of ketogenic diet, ketone supplementation and hyperbaric oxygen therapy. PLoS One 2015; 10: e0127407. https://doi.org/10.1371/journal.pone.0127407
Lin PY, Sung PH, Chung SY, Hsu SL, Chung WJ, Sheu JJ, Hsueh SK, Chen KH, Wu RW, Yip HK. Hyperbaric Oxygen Therapy Enhanced Circulating Levels of Endothelial Progenitor Cells and Angiogenesis Biomarkers, Blood Flow, in Ischemic Areas in Patients with Peripheral Arterial Occlusive Disease. J Clin Med 2018; 7(12): 548. https://doi.org/10.3390/jcm7120548
Memar MY, Yekani M, Alizadeh N, Baghi HB. Hyperbaric oxygen therapy: Antimicrobial mechanisms and clinical application for infections. Biomed Pharmacother 2019; 109: 440-447. https://doi.org/10.1016/j.biopha.2018.10.142
Yang C, Liu G, Zeng X, Xiang Y, Chen X, Le W. Therapeutic effects of long-term HBOT on Alzheimer's disease neuropathologies and cognitive impairment in APPswe/PS1dE9 mice. Redox Biol 2024; 70: 103006. https://doi.org/10.1016/j.redox.2023.103006
Hink J, Jansen E. Are superoxide and/or hydrogen peroxide responsible for some of the beneficial effects of hyperbaric oxygen therapy? Medical Hypotheses 2001; 57: 764-769. https://doi.org/10.1054/mehy.2001.1488
- Downloads
- Published
- 2024-06-12
- Issue
- Vol. 13 (2024)
- Section
- Articles
- License
-

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Similar Articles
- Tatiana Levkovich, Theofilos Poutahidis, Kelsey Cappelle, Mark B. Smith, Allison Perrotta, Eric J. Alm , Susan E. Erdman , ‘Hygienic’ Lymphocytes Convey Increased Cancer Risk , Journal of Analytical Oncology: Vol. 3 No. 3 (2014)
- R.B. Bayramov, R.T. Abdullayeva, S.E. Huseynova, F.R. Bayramli, Postoperative Mortality Rates following Total Gastrectomy for Gastric Cancer: Experience of a Single Surgical Team , Journal of Analytical Oncology: Vol. 11 (2022)
- Zahra Jabbarpour, Mohammad H. Ghahremani, Massoud Saidijam, Jafar Kiani, Naser Ahmadbeigi, Trends of Stem Cell-Based Clinical Trials in Gastrointestinal Tract Diseases , Journal of Analytical Oncology: Vol. 9 (2020)
- A. Taqaddas, E-Survey: Current Status of Proton Beam Therapy in USA , Journal of Analytical Oncology: Vol. 10 (2021)
- Kenji Ina, Ryuichi Furuta, Takae Kataoka, Sayaka Sugiura, Satoshi Kayukawa, Takayuki Kanamori, Takaki Kikuchi, Megumi Kabeya, Satoshi Hibi , Shu Yuasa , Adverse Effects of Bevacizumab During Treatment for Metastatic Colorectal Cancer , Journal of Analytical Oncology: Vol. 4 No. 1 (2015)
- Ada Morgan Godwin, Na’Turie Ward, Christopher Krauss, Hirendranath Banerjee, Gloria Payne, Dolapo Adedeji, Initial Evaluation of Dihydroartemisinin (DHA), Metformin and Taro Extract in Combination with Cisplatin for Enhanced Cytotoxicity in Triple-Negative Breast Cancer (TNBC) Cell Lines , Journal of Analytical Oncology: Vol. 15 (2026)
- Kenji Ina, Ryuichi Furuta, Tomoko Nishio, Satoshi Kayukawa, Takae Kataoka, Haruhito Totani, Takashi Kanamori, Takaki Kikuchi, Shun Umeda, Tamio Fujita, Pathological Complete Response Induced by the Combination Therapy of Gemcitabine and 24-h Infusion of Cisplatin in Two Cases Initially Diagnosed as Node-Positive Advanced Urothelial Carcinomas , Journal of Analytical Oncology: Vol. 2 No. 4 (2013)
- Javier Garde Noguera, Elena Evgenyeva, Mireia Gil Raga, Asunción Juárez Marroquí, Juan Manuel Gasent Blesa, Juan Laforga, Laia Bernet, Mónica Clemente Císcar, Carlos Camps Herrero, Antonio Llombart Cussac, Role of Primary Tumour Resection and Addition of Bevacizumab to Chemotherapy in the Management of Advanced Colorectal Cancer with Inoperable Metastasis: A Retrospective Analysis , Journal of Analytical Oncology: Vol. 2 No. 4 (2013)
- Vladimir Zaichick, Sofia Zaichick, Sinclair Wynchank, Intracellular Zinc Excess as One of the Main Factors in the Etiology of Prostate Cancer , Journal of Analytical Oncology: Vol. 5 No. 3 (2016)
- Arun Chairmadurai, Harish Chandra Goel, Sandeep Jain, Aklank Jain, Hridayesh Prakash, Ra-SBRT is Potential Immune Adjuvant for Innate Immune Cell Populations in Advance Stage NSCLC Patients , Journal of Analytical Oncology: Vol. 8 (2019)
You may also start an advanced similarity search for this article.
